Circular to Shareholders | Duopharma Biotech Berhad

Circular to Shareholders : 2019

No	Notice Date	Title
1	14 January 2019	Circular to Shareholders in Relation to the Proposed Change of The Company’s Name From “CCM Duopharma Biotech Berhad” to “Duopharma Biotech Berhad” and Notice of Meeting of Members

Circular to Shareholders : 2018

No	Notice Date	Title
3	16 May 2018	Circular to Shareholders in relation to the (Part A) Proposed Acquisition of 806,450 Common Shares in Pangen Biotech, Inc. (Part B) Independent Advise Letter from Kenanga Investment Bankto the Non-Interested Shareholders of CCMD and Notice of Extraordinary General Meeting
2	30 April 2018	Circular to Shareholders in relation to the (1) Proposed Bonus Issue; (2) Proposed Establishment of a Dividend Reinvestment Plan; and (3) Notice of Extraordinary General Meeting